A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants
about
Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its DerivativesEmerging data on androgen receptor splice variants in prostate cancerNovel Aryl Hydrocarbon Receptor Agonist Suppresses Migration and Invasion of Breast Cancer CellsTCF21 and the environmental sensor aryl-hydrocarbon receptor cooperate to activate a pro-inflammatory gene expression program in coronary artery smooth muscle cellsA novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.Icaritin induces apoptotic and autophagic cell death in human glioblastoma cells.TRAF6 Mediates Suppression of Osteoclastogenesis and Prevention of Ovariectomy-Induced Bone Loss by a Novel Prenylflavonoid.Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target.Metabolite Profiling, Pharmacokinetics, and In Vitro Glucuronidation of Icaritin in Rats by Ultra-Performance Liquid Chromatography Coupled with Mass Spectrometry.Genomic variants link to hepatitis C racial disparities.A novel anticancer agent icaritin inhibited proinflammatory cytokines in TRAMP mice.Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice.
P2860
Q26738330-F26D7FA4-82F0-46C2-80CB-0FD9DC024EA0Q28077830-6FE52684-21A9-4031-82CB-2F17C1C542A9Q28554754-BF7507E5-2940-4E4C-B9ED-6BA82601CCE9Q33713712-8A7693F0-16C0-4916-BA25-B78CDB8F093EQ36544739-6AB9BF55-4D4C-4638-9CD7-0AE4635DCC74Q38728168-8780789F-6DDA-4BD7-B5F1-66707FE12830Q38733018-AE1571CC-575C-4A7C-8BDD-929299110213Q39309007-4F99786A-B651-4DC6-97BB-19BF203EB968Q41141804-2CAD33B9-B28B-463D-8935-2EC036057B73Q41708713-E1D5FB0F-91FC-4C1C-A303-D0697DBE0781Q51711371-5D5F6521-3655-4031-B6C0-5F7030A5B51AQ53784890-DB90CE5C-B3A1-4D2A-BAA6-0612B530B486
P2860
A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A novel prostate cancer therap ...... ceptor and its splice variants
@ast
A novel prostate cancer therap ...... ceptor and its splice variants
@en
type
label
A novel prostate cancer therap ...... ceptor and its splice variants
@ast
A novel prostate cancer therap ...... ceptor and its splice variants
@en
prefLabel
A novel prostate cancer therap ...... ceptor and its splice variants
@ast
A novel prostate cancer therap ...... ceptor and its splice variants
@en
P2093
P2860
P356
P1433
P1476
A novel prostate cancer therap ...... ceptor and its splice variants
@en
P2093
Chong Yang
Edwin Cheung
Fen-Fen Soon
Inthrani R Indran
M H Eileen Tan
P2860
P304
P356
10.1093/CARCIN/BGV040
P407
P577
2015-04-23T00:00:00Z